• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用溶剂分配法制备的乙酰水杨酸-尤特奇RS100微球的物理化学评价

Physico-chemical evaluation of acetylsalicylic acid-Eudragit RS100 microspheres prepared using a solvent-partition method.

作者信息

Vachon M G, Nairn J G

机构信息

Faculty of Pharmacy, University of Toronto, Ontario, Canada.

出版信息

J Microencapsul. 1995 May-Jun;12(3):287-305. doi: 10.3109/02652049509010297.

DOI:10.3109/02652049509010297
PMID:7650593
Abstract

Controlled release homogeneous matrix microspheres containing acetylsalicylic acid (ASA) were prepared by a simple mechanical process using Eudragit RS100 as the matrix polymer. A drug-polymer solution in a binary solvent of methylene chloride/acetone (9:1) was prepared and infused at a rate of 15 microliters/min as small droplets into a flowing stream of mineral oil where partition of the solvent occurred. A series of experiments was conducted in which the polymer to drug ratio in the infusion solution was fixed at 5:1, 4:1, 3:1 or 2:1 while varying the infusion solution viscosity by altering the infusion solution total solids concentration. Results indicate that microsphere mean particle size was maintained at 200-300 microns once the infusion solution viscosity exceeded 2 cps. The physical state of the ASA incorporated into the microspheres, as confirmed by SEM and thermal analysis, was amorphous in nature until a drug loading of 24% was reached. Drug loading for each polymer to drug ratio increased in a proportional manner with respect to the initial drug concentration of the infusion solution. Dissolution release profiles were found to be biphasic and best analysed according to the semi-empirical equation of Ritger-Peppas, Mt/Mx = k2tn, for the initial phase and by the square-root model of Higuchi, Qt = k1t1/2 for the latter phase. This difference was attributed to the lack of a barrier effect to the drug diffusion process during the latter dissolution phase when the microspheres are fully hydrated.

摘要

以Eudragit RS100为基质聚合物,通过简单的机械工艺制备了含乙酰水杨酸(ASA)的控释均匀基质微球。制备了二氯甲烷/丙酮(9:1)二元溶剂中的药物 - 聚合物溶液,并以15微升/分钟的速率作为小液滴注入流动的矿物油流中,在其中发生溶剂分配。进行了一系列实验,其中输注溶液中聚合物与药物的比例固定为5:1、4:1、3:1或2:1,同时通过改变输注溶液的总固体浓度来改变输注溶液的粘度。结果表明,一旦输注溶液粘度超过2厘泊,微球平均粒径保持在200 - 300微米。通过扫描电子显微镜(SEM)和热分析证实,掺入微球中的ASA的物理状态在达到24%的载药量之前本质上是无定形的。每种聚合物与药物比例的载药量相对于输注溶液的初始药物浓度成比例增加。发现溶出释放曲线是双相的,对于初始阶段,根据Ritger - Peppas的半经验方程Mt/Mx = k2tn进行最佳分析,对于后一阶段,根据Higuchi的平方根模型Qt = k1t1/2进行分析。这种差异归因于在后一溶出阶段微球完全水合时对药物扩散过程缺乏屏障作用。

相似文献

1
Physico-chemical evaluation of acetylsalicylic acid-Eudragit RS100 microspheres prepared using a solvent-partition method.采用溶剂分配法制备的乙酰水杨酸-尤特奇RS100微球的物理化学评价
J Microencapsul. 1995 May-Jun;12(3):287-305. doi: 10.3109/02652049509010297.
2
The influence of microencapsulation using Eudragit RS100 on the hydrolysis kinetics of acetylsalicylic acid.使用尤特奇RS100进行微囊化对乙酰水杨酸水解动力学的影响。
J Microencapsul. 1997 May-Jun;14(3):281-301. doi: 10.3109/02652049709051133.
3
Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.茶碱载药 Eudragit RS 100 微球的乳液-溶剂扩散/蒸发技术制备、表征及体外评价。
Pharm Dev Technol. 2011 Nov-Dec;16(6):637-44. doi: 10.3109/10837450.2010.508075. Epub 2010 Aug 19.
4
Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.通过乳液溶剂蒸发法和乳液非溶剂添加法制备的含茶碱醋酸丁酸纤维素微球的微观性质及释放行为
Arch Pharm Res. 2009 Jul;32(7):1019-28. doi: 10.1007/s12272-009-1707-y. Epub 2009 Jul 31.
5
Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.齐多夫定负载的由Eudragit RS 100、RL 100及其组合制成的微球的制备及体外溶出曲线
Acta Pol Pharm. 2011 May-Jun;68(3):409-15.
6
Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.采用准乳液溶剂扩散法制备及评价含丙烯酸聚合物(尤特奇)的布洛芬缓释微球:变量的影响
Acta Pol Pharm. 2006 Nov-Dec;63(6):521-34.
7
Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method.聚合物溶液相的粘度及其他控制乳液溶剂蒸发法制备的茶碱微球溶解的因素。
J Microencapsul. 2003 Jan-Feb;20(1):57-65.
8
Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.采用油包油(o/o)溶剂蒸发法将卵清蛋白微囊化于聚(丙交酯-乙交酯)中。
J Microencapsul. 1996 Sep-Oct;13(5):509-18. doi: 10.3109/02652049609026036.
9
Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.载环丙沙星的Eudragit RS100或RL100/聚乳酸-羟基乙酸共聚物纳米粒的评估
Int J Pharm. 2006 May 11;314(1):72-82. doi: 10.1016/j.ijpharm.2006.01.041. Epub 2006 Apr 5.
10
A method to control particle size of cellulose acetate trimellitate microspheres.
J Microencapsul. 1993 Apr-Jun;10(2):181-94. doi: 10.3109/02652049309104384.

引用本文的文献

1
Controllable Drug Release Behavior of Polylactic Acid (PLA) Surgical Suture Coating with Ciprofloxacin (CPFX)-Polycaprolactone (PCL)/Polyglycolide (PGA).聚乳酸(PLA)手术缝线涂层与环丙沙星(CPFX)-聚己内酯(PCL)/聚乙交酯(PGA)的可控药物释放行为
Polymers (Basel). 2020 Feb 1;12(2):288. doi: 10.3390/polym12020288.